148 related articles for article (PubMed ID: 26037731)
1. The Impact of Inpatient Versus Outpatient Initiation on Early Warfarin Dosing.
Kasner SE; Wang L; French B; Messe SR; Horenstein R; Mohler ER; Muldowney JA; Ellenberg J; Kimmel SE
Am J Cardiovasc Drugs; 2015 Aug; 15(4):267-74. PubMed ID: 26037731
[TBL] [Abstract][Full Text] [Related]
2. A pharmacogenetic versus a clinical algorithm for warfarin dosing.
Kimmel SE; French B; Kasner SE; Johnson JA; Anderson JL; Gage BF; Rosenberg YD; Eby CS; Madigan RA; McBane RB; Abdel-Rahman SZ; Stevens SM; Yale S; Mohler ER; Fang MC; Shah V; Horenstein RB; Limdi NA; Muldowney JA; Gujral J; Delafontaine P; Desnick RJ; Ortel TL; Billett HH; Pendleton RC; Geller NL; Halperin JL; Goldhaber SZ; Caldwell MD; Califf RM; Ellenberg JH;
N Engl J Med; 2013 Dec; 369(24):2283-93. PubMed ID: 24251361
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
Le Gal G; Carrier M; Tierney S; Majeed H; Rodger M; Wells PS
J Thromb Haemost; 2010 Jan; 8(1):90-4. PubMed ID: 19874475
[TBL] [Abstract][Full Text] [Related]
4. A systematic analysis and comparison of warfarin initiation strategies.
French B; Wang L; Gage BF; Horenstein RB; Limdi NA; Kimmel SE
Pharmacogenet Genomics; 2016 Oct; 26(10):445-52. PubMed ID: 27383664
[TBL] [Abstract][Full Text] [Related]
5. Warfarin initiation nomograms for venous thromboembolism.
Garcia P; Ruiz W; Loza Munárriz C
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD007699. PubMed ID: 26822633
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial.
Marcatto LR; Sacilotto L; Bueno CT; Facin M; Strunz CM; Darrieux FC; Scanavacca MI; Krieger JE; Pereira AC; Santos PC
BMC Cardiovasc Disord; 2016 Nov; 16(1):224. PubMed ID: 27855643
[TBL] [Abstract][Full Text] [Related]
7. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen.
Siguret V; Gouin I; Debray M; Perret-Guillaume C; Boddaert J; Mahé I; Donval V; Seux ML; Romain-Pilotaz M; Gisselbrecht M; Verny M; Pautas E
Am J Med; 2005 Feb; 118(2):137-42. PubMed ID: 15694897
[TBL] [Abstract][Full Text] [Related]
8. Clinical versus fixed warfarin dosing and the impact on quality of anticoagulation (The ClinFix trial).
Fahmi AM; El Bardissy A; Saad MO; Elshafei MN; Bader L; Mahfouz A; Kasem M; Abdelsamad O; Elzouki A; Aquilante CL; Mraiche F; Soaly E; El Madhoun I; Asaad N; Arabi A; Alhmoud E; Elewa H
Clin Transl Sci; 2024 Jun; 17(6):e13797. PubMed ID: 38859626
[TBL] [Abstract][Full Text] [Related]
9. Validation of pharmacogenetic algorithms and warfarin dosing table in Egyptian patients.
Bazan NS; Sabry NA; Rizk A; Mokhtar S; Badary O
Int J Clin Pharm; 2012 Dec; 34(6):837-44. PubMed ID: 22851439
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of genotype-guided dosing of warfarin.
Pirmohamed M; Burnside G; Eriksson N; Jorgensen AL; Toh CH; Nicholson T; Kesteven P; Christersson C; Wahlström B; Stafberg C; Zhang JE; Leathart JB; Kohnke H; Maitland-van der Zee AH; Williamson PR; Daly AK; Avery P; Kamali F; Wadelius M;
N Engl J Med; 2013 Dec; 369(24):2294-303. PubMed ID: 24251363
[TBL] [Abstract][Full Text] [Related]
11. Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials.
Tse G; Gong M; Li G; Wong SH; Wu WKK; Wong WT; Roever L; Lee APW; Lip GYH; Wong MCS; Liu T;
Br J Clin Pharmacol; 2018 Sep; 84(9):1868-1882. PubMed ID: 29704269
[TBL] [Abstract][Full Text] [Related]
12. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.
Schulman S; Parpia S; Stewart C; Rudd-Scott L; Julian JA; Levine M
Ann Intern Med; 2011 Nov; 155(10):653-9, W201-3. PubMed ID: 22084331
[TBL] [Abstract][Full Text] [Related]
13. Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic.
Shaw PB; Donovan JL; Tran MT; Lemon SC; Burgwinkle P; Gore J
J Thromb Thrombolysis; 2010 Aug; 30(2):220-5. PubMed ID: 20204461
[TBL] [Abstract][Full Text] [Related]
14. Warfarin Dosing Algorithms and the Need for Human Intervention.
Kasner SE; Wang L; French B; Messé SR; Ellenberg J; Kimmel SE;
Am J Med; 2016 Apr; 129(4):431-7. PubMed ID: 26642907
[TBL] [Abstract][Full Text] [Related]
15. Comparative performance of pharmacogenetics-based warfarin dosing algorithms derived from Caucasian, Asian, and mixed races in Thai population.
Chumnumwat S; Yi K; Lucksiri A; Nosoongnoen W; Chindavijak B; Chulavatnatol S; Sarapakdi A; Nathisuwan S
Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29243335
[TBL] [Abstract][Full Text] [Related]
16. Genotype-guided dosing versus conventional dosing of warfarin: A meta-analysis of 15 randomized controlled trials.
Yang T; Zhou Y; Chen C; Lu M; Ma L; Cui Y
J Clin Pharm Ther; 2019 Apr; 44(2):197-208. PubMed ID: 30593674
[TBL] [Abstract][Full Text] [Related]
17. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.
Gage BF; Bass AR; Lin H; Woller SC; Stevens SM; Al-Hammadi N; Li J; Rodríguez T; Miller JP; McMillin GA; Pendleton RC; Jaffer AK; King CR; Whipple BD; Porche-Sorbet R; Napoli L; Merritt K; Thompson AM; Hyun G; Anderson JL; Hollomon W; Barrack RL; Nunley RM; Moskowitz G; Dávila-Román V; Eby CS
JAMA; 2017 Sep; 318(12):1115-1124. PubMed ID: 28973620
[TBL] [Abstract][Full Text] [Related]
18. Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy.
Ferder NS; Eby CS; Deych E; Harris JK; Ridker PM; Milligan PE; Goldhaber SZ; King CR; Giri T; McLeod HL; Glynn RJ; Gage BF
J Thromb Haemost; 2010 Jan; 8(1):95-100. PubMed ID: 19874474
[TBL] [Abstract][Full Text] [Related]
19. A Randomized Trial Comparing Standard of Care to Bayesian Warfarin Dose Individualization.
Xue L; Ma G; Holford N; Qin Q; Ding Y; Hannam JA; Ding X; Fan H; Ji Z; Yang B; Shen H; Shen Z; Miao L
Clin Pharmacol Ther; 2024 Jun; 115(6):1316-1325. PubMed ID: 38439157
[TBL] [Abstract][Full Text] [Related]
20. Safety of warfarin dosing in the intensive care unit following the Fontan procedure.
Thomas CA; Taylor K; Schamberger MS; Rotta AT
Congenit Heart Dis; 2014; 9(4):361-5. PubMed ID: 25247218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
